eIF3f Mediates SGOC Pathway Reprogramming by Enhancing Deubiquitinating Activity in Colorectal Cancer. 2023

Qihao Pan, and Fenghai Yu, and Huilin Jin, and Peng Zhang, and Xiaoling Huang, and Jingxuan Peng, and Xiaoshan Xie, and Xiangli Li, and Ning Ma, and Yue Wei, and Weijie Wen, and Jieping Zhang, and Boyu Zhang, and Hongyan Yu, and Yuanxun Xiao, and Ran-Yi Liu, and Qingxin Liu, and Xiangqi Meng, and Mong-Hong Lee
Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China.

Numerous studies have demonstrated that individual proteins can moonlight. Eukaryotic Initiation translation factor 3, f subunit (eIF3f) is involved in critical biological functions; however, its role independent of protein translation in regulating colorectal cancer (CRC) is not characterized. Here, it is demonstrated that eIF3f is upregulated in CRC tumor tissues and that both Wnt and EGF signaling pathways are participating in eIF3f's oncogenic impact on targeting phosphoglycerate dehydrogenase (PHGDH) during CRC development. Mechanistically, EGF blocks FBXW7β-mediated PHGDH ubiquitination through GSK3β deactivation, and eIF3f antagonizes FBXW7β-mediated PHGDH ubiquitination through its deubiquitinating activity. Additionally, Wnt signals transcriptionally activate the expression of eIF3f, which also exerts its deubiquitinating activity toward MYC, thereby increasing MYC-mediated PHGDH transcription. Thereby, both impacts allow eIF3f to elevate the expression of PHGDH, enhancing Serine-Glycine-One-Carbon (SGOC) signaling pathway to facilitate CRC development. In summary, the study uncovers the intrinsic role and underlying molecular mechanism of eIF3f in SGOC signaling, providing novel insight into the strategies to target eIF3f-PHGDH axis in CRC.

UI MeSH Term Description Entries
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012694 Serine A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids. L-Serine,L Serine
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Qihao Pan, and Fenghai Yu, and Huilin Jin, and Peng Zhang, and Xiaoling Huang, and Jingxuan Peng, and Xiaoshan Xie, and Xiangli Li, and Ning Ma, and Yue Wei, and Weijie Wen, and Jieping Zhang, and Boyu Zhang, and Hongyan Yu, and Yuanxun Xiao, and Ran-Yi Liu, and Qingxin Liu, and Xiangqi Meng, and Mong-Hong Lee
April 2023, Environmental science and pollution research international,
Qihao Pan, and Fenghai Yu, and Huilin Jin, and Peng Zhang, and Xiaoling Huang, and Jingxuan Peng, and Xiaoshan Xie, and Xiangli Li, and Ning Ma, and Yue Wei, and Weijie Wen, and Jieping Zhang, and Boyu Zhang, and Hongyan Yu, and Yuanxun Xiao, and Ran-Yi Liu, and Qingxin Liu, and Xiangqi Meng, and Mong-Hong Lee
January 2022, Frontiers in oncology,
Qihao Pan, and Fenghai Yu, and Huilin Jin, and Peng Zhang, and Xiaoling Huang, and Jingxuan Peng, and Xiaoshan Xie, and Xiangli Li, and Ning Ma, and Yue Wei, and Weijie Wen, and Jieping Zhang, and Boyu Zhang, and Hongyan Yu, and Yuanxun Xiao, and Ran-Yi Liu, and Qingxin Liu, and Xiangqi Meng, and Mong-Hong Lee
January 2017, International journal of oncology,
Qihao Pan, and Fenghai Yu, and Huilin Jin, and Peng Zhang, and Xiaoling Huang, and Jingxuan Peng, and Xiaoshan Xie, and Xiangli Li, and Ning Ma, and Yue Wei, and Weijie Wen, and Jieping Zhang, and Boyu Zhang, and Hongyan Yu, and Yuanxun Xiao, and Ran-Yi Liu, and Qingxin Liu, and Xiangqi Meng, and Mong-Hong Lee
August 2012, International journal of molecular medicine,
Qihao Pan, and Fenghai Yu, and Huilin Jin, and Peng Zhang, and Xiaoling Huang, and Jingxuan Peng, and Xiaoshan Xie, and Xiangli Li, and Ning Ma, and Yue Wei, and Weijie Wen, and Jieping Zhang, and Boyu Zhang, and Hongyan Yu, and Yuanxun Xiao, and Ran-Yi Liu, and Qingxin Liu, and Xiangqi Meng, and Mong-Hong Lee
December 2019, Genes & diseases,
Qihao Pan, and Fenghai Yu, and Huilin Jin, and Peng Zhang, and Xiaoling Huang, and Jingxuan Peng, and Xiaoshan Xie, and Xiangli Li, and Ning Ma, and Yue Wei, and Weijie Wen, and Jieping Zhang, and Boyu Zhang, and Hongyan Yu, and Yuanxun Xiao, and Ran-Yi Liu, and Qingxin Liu, and Xiangqi Meng, and Mong-Hong Lee
January 2023, International journal of biological sciences,
Qihao Pan, and Fenghai Yu, and Huilin Jin, and Peng Zhang, and Xiaoling Huang, and Jingxuan Peng, and Xiaoshan Xie, and Xiangli Li, and Ning Ma, and Yue Wei, and Weijie Wen, and Jieping Zhang, and Boyu Zhang, and Hongyan Yu, and Yuanxun Xiao, and Ran-Yi Liu, and Qingxin Liu, and Xiangqi Meng, and Mong-Hong Lee
September 2014, Neuron,
Qihao Pan, and Fenghai Yu, and Huilin Jin, and Peng Zhang, and Xiaoling Huang, and Jingxuan Peng, and Xiaoshan Xie, and Xiangli Li, and Ning Ma, and Yue Wei, and Weijie Wen, and Jieping Zhang, and Boyu Zhang, and Hongyan Yu, and Yuanxun Xiao, and Ran-Yi Liu, and Qingxin Liu, and Xiangqi Meng, and Mong-Hong Lee
January 2023, Journal of cellular biochemistry,
Qihao Pan, and Fenghai Yu, and Huilin Jin, and Peng Zhang, and Xiaoling Huang, and Jingxuan Peng, and Xiaoshan Xie, and Xiangli Li, and Ning Ma, and Yue Wei, and Weijie Wen, and Jieping Zhang, and Boyu Zhang, and Hongyan Yu, and Yuanxun Xiao, and Ran-Yi Liu, and Qingxin Liu, and Xiangqi Meng, and Mong-Hong Lee
November 2005, Clinical colorectal cancer,
Qihao Pan, and Fenghai Yu, and Huilin Jin, and Peng Zhang, and Xiaoling Huang, and Jingxuan Peng, and Xiaoshan Xie, and Xiangli Li, and Ning Ma, and Yue Wei, and Weijie Wen, and Jieping Zhang, and Boyu Zhang, and Hongyan Yu, and Yuanxun Xiao, and Ran-Yi Liu, and Qingxin Liu, and Xiangqi Meng, and Mong-Hong Lee
January 2024, Cellular and molecular life sciences : CMLS,
Copied contents to your clipboard!